John R Stuelpnagel - Net Worth and Insider Trading
John R Stuelpnagel Net Worth
The estimated net worth of John R Stuelpnagel is at least $105 Million dollars as of 2024-12-11. John R Stuelpnagel is the Sr VP and COO, Director of Illumina Inc and owns about 675,672 shares of Illumina Inc (ILMN) stock worth over $99 Million. John R Stuelpnagel is also the Director of 10x Genomics Inc and owns about 333,736 shares of 10x Genomics Inc (TXG) stock worth over $5 Million. Details can be seen in John R Stuelpnagel's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John R Stuelpnagel has not made any transactions after 2023-06-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of John R Stuelpnagel
John R Stuelpnagel Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John R Stuelpnagel owns 2 companies in total, including 10x Genomics Inc (TXG) , and Illumina Inc (ILMN) .
Click here to see the complete history of John R Stuelpnagel’s form 4 insider trades.
Insider Ownership Summary of John R Stuelpnagel
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TXG | 10x Genomics Inc | 2023-06-05 | director |
| ILMN | Illumina Inc | 2008-03-27 | VP Business Development |
John R Stuelpnagel Latest Holdings Summary
John R Stuelpnagel currently owns a total of 2 stocks. Among these stocks, John R Stuelpnagel owns 675,672 shares of Illumina Inc (ILMN) as of March 27, 2008, with a value of $99 Million and a weighting of 94.86%. John R Stuelpnagel also owns 333,736 shares of 10x Genomics Inc (TXG) as of June 5, 2023, with a value of $5 Million and a weighting of 5.14%.
Latest Holdings of John R Stuelpnagel
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ILMN | Illumina Inc | 2008-03-27 | 675,672 | 146.97 | 99,300,135 |
| TXG | 10x Genomics Inc | 2023-06-05 | 333,736 | 16.12 | 5,378,389 |
Holding Weightings of John R Stuelpnagel
John R Stuelpnagel Form 4 Trading Tracker
According to the SEC Form 4 filings, John R Stuelpnagel has made a total of 0 transactions in Illumina Inc (ILMN) over the past 5 years. The most-recent trade in Illumina Inc is the sale of 10,000 shares on March 27, 2008, which brought John R Stuelpnagel around $372,250.
According to the SEC Form 4 filings, John R Stuelpnagel has made a total of 35 transactions in 10x Genomics Inc (TXG) over the past 5 years, including 0 buys and 35 sells. The most-recent trade in 10x Genomics Inc is the sale of 10,000 shares on June 5, 2023, which brought John R Stuelpnagel around $548,900.
Insider Trading History of John R Stuelpnagel
- 1
John R Stuelpnagel Trading Performance
John R Stuelpnagel Ownership Network
Ownership Network List of John R Stuelpnagel
Ownership Network Relation of John R Stuelpnagel
John R Stuelpnagel Owned Company Details
What does 10x Genomics Inc do?
Who are the key executives at 10x Genomics Inc?
John R Stuelpnagel is the director of 10x Genomics Inc. Other key executives at 10x Genomics Inc include director & 10 percent owner & Chief Executive Officer Serge Saxonov , director & See Remarks Benjamin J. Hindson , and Chief Financial Officer Justin J. Mcanear .
10x Genomics Inc (TXG) Insider Trades Summary
Over the past 18 months, John R Stuelpnagel made no insider transaction in 10x Genomics Inc (TXG). Other recent insider transactions involving 10x Genomics Inc (TXG) include a net sale of 96,037 shares made by Serge Saxonov , a net sale of 44,666 shares made by Benjamin J. Hindson , and a net sale of 11,119 shares made by Justin J. Mcanear .
In summary, during the past 3 months, insiders sold 12,500 shares of 10x Genomics Inc (TXG) in total and bought 0 shares, with a net sale of 12,500 shares. During the past 18 months, 179,703 shares of 10x Genomics Inc (TXG) were sold and 0 shares were bought by its insiders, resulting in a net sale of 179,703 shares.
10x Genomics Inc (TXG)'s detailed insider trading history can be found in Insider Trading Tracker table.
10x Genomics Inc Insider Transactions
John R Stuelpnagel Mailing Address
Above is the net worth, insider trading, and ownership report for John R Stuelpnagel. You might contact John R Stuelpnagel via mailing address: 10x Genomics, Inc., 6230 Stoneridge Mall Road, Pleasanton Ca 94588.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
